TLX Buy Disclosure
Smith Darren Charlton · SEC Form 4 · Filed Sep 14, 2026
Buy
Calculated transaction value
$20K
Smith Darren Charlton Group Chief Financial Officer
TLX
Transaction date
Sep 7, 2026
Public filing date
Sep 14, 2026
Filing lag
Filed 7 days later
TLX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 2,071 shares @ $9.66
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001628280-26-061944
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$20K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Telix Pharmaceuticals Ltd TLX Current | Buy | Sep 7, 2026 | $20K |